Meta-Analysis
Copyright ©The Author(s) 2025.
World J Nephrol. Mar 25, 2025; 14(1): 101078
Published online Mar 25, 2025. doi: 10.5527/wjn.v14.i1.101078
Table 2 Baseline patient characteristics, n (%)/mean ± SD
Ref.
Age (year)
Male
eGFR (mL/min)
Serum HCO3- (mmol/L)
Serum K+ (mmol/L)
Serum Na+ (mmol/L)
Intervention
Control
Intervention
Control
Intervention
Control
Intervention
Control
Intervention
Control
Intervention
Control
Mathur et al[28]37.5 ± 1743.5 ± 10.5 12 (60)13 (65)--19.49 ± 5.5119.35 ± 3.74----
Ashurst et al[27]54.78 ± 2.5654.77 ± 2.3435 (52)34 (51)--19.8 ± 2.219.9 ± 1.5----
Goraya et al[26]54.2 ± 5.353.9 ± 6.918 (51)20 (56)----4.1 ± 0.24.1 ± 0.2139.9 ± 1.2139.8 ± 1.3
Abramowitz et al[35]63.1 ± 10.8-8 (40)-32.9 ± 8.9-23.0 ± 2.4-4.6 ± 0.4---
Goraya et al[25]53.6 ± 5.353.9 ± 4.816 (44)16 (44)----4.24 ± 0.124.29 ± 0.14--
Jeong et al[36]53.3 ± 13.555.8 ± 12.721 (52.5)26 (57.5)16.7 ± 6.117.7 ± 6.45.25 ± 0.715.44 ± 0.63--
Bellasi et al[29]64.9 ± 11.866.0 ± 12.947 (66)36 (48)--21.2 ± 1.921.6 ± 2.0----
Yan et al[30]53.10 ± 6.1153.10 ± 8.6625 (59.5)24 (57.1)19.09 ± 2.2618.43 ± 1.8916.49 ± 1.2216.14 ± 1.40----
Kendrick et al[31]59 ± 12-10 (50)-25 ± 824 ± 819.3 ± 2.919.7 ± 2.3----
Di Iorio et al[22]67.6 ± 15.168.1 ± 14.7234 (62.2)224 (61.5)33.4 ± 12.436.9 ± 10.821.7 ± 2.621.4 ± 2.14.9 ± 0.54.9 ± 0.6139 ± 2.9139 ± 2.8
Aigner et al[24]59.94 ± 12.4653.12 ± 17.7412 (66.7)11 (52.9)23.64 ± 5.8727.45 ± 10.0518.78 ± 1.5919.28 ± 1.554.83 ± 0.474.94 ± 0.61140 ± 3.03139 ± 2.6
Goraya et al[23]53.6 ± 5.353.9 ± 4.816 (44.4)16 (44.4)39.6 ± 6.639.5 ± 6.9------
Raphael et al[17]HD: 67 ± 11 LD: 66 ± 1466 ± 11HD: 61 (68) LD: 69 (60)39 (75)HD: 36 ± 10
LD: 37 ± 10
35 ± 9HD: 24 ± 2
LD: 24 ± 2
24 ± 24.4 ± 0.44.5 ± 0.5--
Kittiskulnam et al[28]61.2 ± 9.8 61.2 ± 9.8 12 (57.1)12 (57.1)32.4 ± 14.1-21.0 ± 2.1-----
Melamed et al[19]60.3 ± 14.161.6 ± 10.936 (49)33 (44)36.4 ± 11.436.2 ± 11.124.0 ± 2.224.1 ± 2.64.5 ± 0.54.6 ± 0.5--
Dubey et al[33]50.12 ± 11.650.30 ± 11.468 (72.3)66 (70.2)29.2 (27-31.3)31.5 (29.3-33.8)18.1 (17.7-18.6)18.1 (17.6-18.6)----
Witham et al[20]73.9 ± 7.674.0 ± 6.6110 (72.4)104 (70.3)19.7 ± 6.518.2 ± 6.420.6 ± 2.620.1 ± 2.54.9 ± 0.54.9 ± 0.5--
Alva et al[21]--23 (69.7)25 (73.53)22.39 ± 4.0821.21 ± 4.3716.62 ± 3.0516.84 ± 2.17----
Gaggl et al[34]58 ± 12.856 ± 16.515 (62)14 (61)25.33 ± 7.527 ± 9.718.8 ± 1.819.2 ± 1.5----
Bovée et al[16]61 ± 1761 ± 1411 (73)14 (93)21 ± 622 ± 320.8 ± 3.921.8 ± 2.95.1 ± 0.75.0 ± 0.6
--
Mohebbi et al[32]55.7 ± 13.255.3 ± 13.882 (69)85 (70)48.2 ± 16.347.7 ± 15.821.3 ± 2.621.0 ± 2.7----
Sorohan et al[15]57.37 ± 10.2557.95 ± 10.2235 (56.5)35 (56.5)23.68 ± 9.0524.93 ± 6.7017.16 ± 1.6217.53 ± 2.055.00 ± 0.344.88 ± 0.44138.71 ± 1.41138.44 ± 2.61